Impact of Drug Shortages on Consumer Costs

As of August 6, 2020, Heparin has been listed in the Food and Drug Administration’s List of Essential Medicines. 4. [...] [3] Vizient Inc, "Drug Shortages and Labor Costs. Measuring the Hidden Costs of Drug Shortages on U.S. [...] Food and Drug Administration, "Search List of Extended Use Dates to Assist with Drug Shortages," 17 December 2021. [Online]. [...] Food and Drug Administration, "Drug and Biologic Essential Medicines, Medical Countermeasures, and Critical Inputs for the List Described in Section 3(c) of the Executive Order 13944," 2020. [Online]. [...] [64] Office of the Assistant Secretary for Planning and Evaluation (ASPE), "Comprehensive Plan for Addressing High Drug Prices: A Report in Response to the Executive Order on Competition in the American Economy," 2021. [65] U.S. [...] Food and Drug Administration, "Search List of Extended Use Dates to Assist with Drug Shortages," 11 02 2021. [Online]. [...] Food and Drug Administration, "Importation of Drugs Originally Intended for Foreign Markets, October 1, 2020," 2020. [Online]. [...] Food and Drug Administration, "Drug and Biologic Essential Medicines, Medical Countermeasures, and Critical Inputs for the List Described in Section 3(c) of the Executive Order 13944," 2021. [Online]. [...] Food and Drug Administration, "Notification to FDA of Issues that May Result in a Prescription Drug or Biological Product Shortage," 2012. [84] T. [...] Food and Drug Administration, "Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act Guidance for Industry," March 2020. [Online].